English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  50947141    在线人数 :  811
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"mo l r"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 11-20 / 70 (共7页)
<< < 1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-02-18T08:46:50Z A case series on the use of circumferential radiofrequency ablation for early esophageal squamous neoplasias in patients with esophageal varices Wang W.-L.; Chang I.-W.; CHIEN-CHUAN CHEN; Chang C.-Y.; Mo L.-R.; Lin J.-T.; Wang H.-P.; Lee C.-T.
臺大學術典藏 2022-02-18T08:26:05Z Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T.
臺大學術典藏 2022-02-18T08:26:04Z Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Yang T.-H.; Kao J.-H.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T.
臺大學術典藏 2022-02-18T08:26:01Z Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; Wu M.-S.; Yang T.-H.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Wu C.-Y.; Lin J.-T.; Tanaka Y.; Chang C.-Y.
臺大學術典藏 2022-02-18T08:25:53Z Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial Hsu Y.-C.; Chen C.-Y.; Chang I.-W.; Chang C.-Y.; Wu C.-Y.; Lee T.-Y.; Wu M.-S.; Bair M.-J.; Chen J.-J.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Huang Y.-T.; Ku W.-H.; Mo L.-R.; Lin J.-T.
臺大學術典藏 2022-02-14T06:28:50Z Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; YU-JEN FANG; Hung H.-W.; Wu C.-Y.; Lin J.-T.
臺大學術典藏 2022-01-25T07:24:19Z Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial Hsu Y.-C.; Chen C.-Y.; Chang I.-W.; Chang C.-Y.; Wu C.-Y.; Lee T.-Y.; MING-SHIANG WU; Bair M.-J.; Chen J.-J.; Chen C.-C.; Tseng C.-H.; Tai C.-M.; Huang Y.-T.; Ku W.-H.; Mo L.-R.; Lin J.-T.
臺大學術典藏 2022-01-25T03:25:12Z Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients Su T.-H.; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; Hsu S.-J.; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; Tseng T.-C.; CHI-LING CHEN; Kao J.-H.; the C-TEAM study group; the Taiwan Liver Diseases Consortium
臺大學術典藏 2022-01-25T02:56:51Z Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods Kuo M.-J.; Mo L.-R.; CHI-LING CHEN
臺大學術典藏 2022-01-24T09:31:33Z Rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Taiwanese treatment experienced hepatitis C virus genotype 1-infected patients Yang C.-C.; Tsai W.-L.; Su W.-W.; Huang C.-F.; Cheng P.-N.; Lo C.-C.; Tseng K.-C.; Mo L.-R.; Wang C.-H.; Hsu S.-J.; Lai H.-C.; Su C.-W.; CHUN-JEN LIU; Peng C.-Y.; Yu M.-L.

显示项目 11-20 / 70 (共7页)
<< < 1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目